What is the difference between Retatrutide and Tirzepatide?
Tirzepatide is an FDA-approved GLP-1/GIP drug. Retatrutide is investigational and adds glucagon receptor activity on top of GLP-1 and GIP. That makes Retatrutide a more experimental triple-agonist, while Tirzepatide has a clearer clinical-use pathway today.
Mechanism
- Tirzepatide: GLP-1 plus GIP.
- Retatrutide: GLP-1 plus GIP plus glucagon.
- Both sit in the weight-loss and metabolic-health conversation.
Approval status
Tirzepatide is approved as a finished drug. Retatrutide is still investigational, so the human safety and access picture is less settled.
Beginner takeaway
The stronger headline data does not automatically make the investigational option the safer or simpler starting point.
Pepdex is an educational reference, not medical advice. Peptides vary in legal, approval, and evidence status. This answer is meant to explain the concept, not prescribe a protocol or replace a qualified clinician.
Helpful next pages
More glp-1 answers
Last updated 2026-07-07.